77 related articles for article (PubMed ID: 21739416)
1. Antipsychotics and venous thromboembolism risk: a meta-analysis.
Zhang R; Dong L; Shao F; Tan X; Ying K
Pharmacopsychiatry; 2011 Jul; 44(5):183-8. PubMed ID: 21739416
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and Antipsychotic Therapy: Unraveling the Thrombosis Risk.
Dho-Nagy EA; Brassai A; Lechsner P; Ureche C; Bán EG
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255892
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Venous Thromboembolism Risk of Antipsychotic Drugs Using Mendelian Randomization Analysis.
Okada H; Tada H; Takamura M
J Atheroscler Thromb; 2024 Apr; 31(4):351-352. PubMed ID: 38417900
[No Abstract] [Full Text] [Related]
4. Association of Antipsychotic Drugs with the Risk of Recurrent Venous Thromboembolism: A Retrospective Study of Data from a Japanese Inpatient Database.
Hashimoto H; Imai S; Yamashita R; Kiyomi A; Sugiura M
Drugs Real World Outcomes; 2024 Mar; 11(1):109-116. PubMed ID: 38015358
[TBL] [Abstract][Full Text] [Related]
5. Second-generation antipsychotics and VTE risk.
DeLoughery EP
Eur J Haematol; 2024 Apr; ():. PubMed ID: 38644355
[No Abstract] [Full Text] [Related]
6. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies.
Barbui C; Conti V; Cipriani A
Drug Saf; 2014 Feb; 37(2):79-90. PubMed ID: 24403009
[TBL] [Abstract][Full Text] [Related]
7. Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence.
Jönsson AK; Schill J; Olsson H; Spigset O; Hägg S
CNS Drugs; 2018 Jan; 32(1):47-64. PubMed ID: 29423659
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic Drugs and Risk of Developing Venous Thromboembolism and Pulmonary Embolism: A Systematic Review and Meta-Analysis.
Arasteh O; Nomani H; Baharara H; Sadjadi SA; Mohammadpour AH; Ghavami V; Sathyapalan T; Sahebkar A
Curr Vasc Pharmacol; 2020; 18(6):632-643. PubMed ID: 32066363
[TBL] [Abstract][Full Text] [Related]
9. The impact of antipsychotics as a risk factor for thromboembolism.
Ogłodek EA; Just MJ; Grzesińska AD; Araszkiewicz A; Szromek AR
Pharmacol Rep; 2018 Jun; 70(3):533-539. PubMed ID: 29674240
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance programme.
Letmaier M; Grohmann R; Kren C; Toto S; Bleich S; Engel R; Gary T; Papageorgiou K; Konstantinidis A; Holl AK; Painold A; Kasper S
World J Biol Psychiatry; 2018 Apr; 19(3):175-186. PubMed ID: 28112047
[TBL] [Abstract][Full Text] [Related]
11. The Risk of Thromboembolism in Users of Antidepressants and Antipsychotics.
Adelborg K; Sundbøll J; Videbech P; Grove EL
Adv Exp Med Biol; 2017; 906():351-361. PubMed ID: 27638627
[TBL] [Abstract][Full Text] [Related]
12. Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies.
Liu Y; Xu J; Fang K; Xu Y; Gao J; Zhou C; Tang X; Fang X; Chen J; Xie C; Zhang F; Zhang X; Wang C
Ther Adv Psychopharmacol; 2021; 11():2045125320982720. PubMed ID: 33505665
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Rate of Antipsychotic Use in Ambulatory Care Patients With a Venous Thromboembolism.
Rarrick C; Saccone N; Hebbard A; Jones B
Ann Pharmacother; 2020 Feb; 54(2):97-104. PubMed ID: 31416330
[No Abstract] [Full Text] [Related]
14. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia.
Schmedt N; Garbe E
J Clin Psychopharmacol; 2013 Dec; 33(6):753-8. PubMed ID: 24052055
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic drugs and risk of pulmonary embolism.
Allenet B; Schmidlin S; Genty C; Bosson JL
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):42-8. PubMed ID: 22052683
[TBL] [Abstract][Full Text] [Related]
16. Mortality in current and former users of clozapine.
Walker AM; Lanza LL; Arellano F; Rothman KJ
Epidemiology; 1997 Nov; 8(6):671-7. PubMed ID: 9345668
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic use and Risk of Venous Thromboembolism: A Meta-Analysis.
Di X; Chen M; Shen S; Cui X
Psychiatry Res; 2021 Feb; 296():113691. PubMed ID: 33421839
[TBL] [Abstract][Full Text] [Related]
18. Impact of psychiatric disorders on the hemodynamic and quality of life outcome of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension: a retrospective study.
Hirose K; Minatsuki S; Saito A; Yagi H; Takeda N; Hatano M; Komuro I
Respir Res; 2023 Nov; 24(1):274. PubMed ID: 37951929
[TBL] [Abstract][Full Text] [Related]
19. The development and validation of a medicines optimisation tool to protect the physical health of people with severe mental illness (OPTIMISE).
Carolan A; Keating D; McWilliams S; Hynes C; O'Neill M; Boland F; Holland S; Strawbridge J; Ryan C
BMC Psychiatry; 2022 Sep; 22(1):585. PubMed ID: 36057589
[TBL] [Abstract][Full Text] [Related]
20. Clozapine-induced pulmonary embolism in a patient with no pre-existing risk factors: A case report.
Kwan JY; Noor M
Clin Case Rep; 2022 Mar; 10(3):e05497. PubMed ID: 35340632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
